EUVIMEDEUVIMED entdecken
Crossref

1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif

Davinder Kumar, Virender Kumar, Harsh Kumar, Aakash Deep, Rakesh Kumar

Cancer Advances · 2022

DOI: 10.53388/2022522018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Advances, 2022. Verfasst von Davinder Kumar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kumar, D., Kumar, V., Kumar, H., Deep, A., & Kumar, R. (2022). 1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif. Cancer Advances. https://doi.org/10.53388/2022522018

Vancouver

Kumar D, Kumar V, Kumar H, Deep A, Kumar R. 1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif. Cancer Advances. 2022. doi:10.53388/2022522018

BibTeX
@article{Kumar2022,
  author = {Kumar, Davinder and Kumar, Virender and Kumar, Harsh and Deep, Aakash and Kumar, Rakesh},
  title = {1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif},
  journal = {Cancer Advances},
  year = {2022},
  doi = {10.53388/2022522018}
}
Kostenlos starten →